Statistical methods in drug combination studies:
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Boca Raton
CRC Press
[2015]
|
| Schriftenreihe: | Chapman & Hall/CRC biostatistics series (Unnumbered)
|
| Schlagworte: | |
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | 1 Online-Ressource (235 pages) |
| ISBN: | 9781482216752 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV042405910 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 150312s2015 |||| o||u| ||||||eng d | ||
| 020 | |a 9781482216752 |c Online |9 978-1-4822-1675-2 | ||
| 035 | |a (OCoLC)904798362 | ||
| 035 | |a (DE-599)BVBBV042405910 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 615.19 | |
| 245 | 1 | 0 | |a Statistical methods in drug combination studies |c edited by Wei Zhao, MedImmune, LLC, Gaithersburg, Maryland, USA; Harry Yang, MedImmune, LLC, Gaithersburg, Maryland, USA. |
| 264 | 1 | |a Boca Raton |b CRC Press |c [2015] | |
| 300 | |a 1 Online-Ressource (235 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Chapman & Hall/CRC biostatistics series (Unnumbered) | |
| 500 | |a Includes bibliographical references and index | ||
| 505 | 0 | |a 1. Drug combination : much promise and many hurdles / Harry Yang and Laura Richman -- 2. Drug combination synergy / Harry Yang, Steven J. Novick, and Wei Zhao -- 3. Drug combination design strategies / Steven J. Novick and John J. Peterson -- 4. Confidence interval for interaction index / Maiying Kong and J. Jack Lee -- 5. Two-stage response surface approaches to modeling drug interaction / Wei Zhao and Harry Yang -- 6. A Bayesian industry approach to phase I combination trials in oncology / Beat Neuenschwander, Alessandro Matano, Zhongwen Tang, Satrajit Roychoudhury, Simon Wandel, Stuart Bailey -- 7. Statistical methodology for evaluation combination therapy in clinical trials / H.M. James Hung, Sue-Jane Wang -- 8. Challenges and opportunities in analysis of drug combination clinical trial data / Yaning Wang, Hao Zhu, Liang Zhao, and Ping Ji -- 9. Statistical computational tools for ADA analysis / Cheng Su | |
| 650 | 4 | |a Drug development | |
| 650 | 4 | |a Drugs |x Research | |
| 650 | 0 | 7 | |a Statistik |0 (DE-588)4056995-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelforschung |0 (DE-588)4003120-2 |2 gnd |9 rswk-swf |
| 653 | |a Electronic books | ||
| 689 | 0 | 0 | |a Arzneimittelforschung |0 (DE-588)4003120-2 |D s |
| 689 | 0 | 1 | |a Statistik |0 (DE-588)4056995-0 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 700 | 1 | |a Zhao, Wei |e Sonstige |4 oth | |
| 700 | 1 | |a Yang, Harry |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 978-1-4822-1674-5 |
| 912 | |a ZDB-38-EBR | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-027841520 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804153063912505344 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV042405910 |
| collection | ZDB-38-EBR |
| contents | 1. Drug combination : much promise and many hurdles / Harry Yang and Laura Richman -- 2. Drug combination synergy / Harry Yang, Steven J. Novick, and Wei Zhao -- 3. Drug combination design strategies / Steven J. Novick and John J. Peterson -- 4. Confidence interval for interaction index / Maiying Kong and J. Jack Lee -- 5. Two-stage response surface approaches to modeling drug interaction / Wei Zhao and Harry Yang -- 6. A Bayesian industry approach to phase I combination trials in oncology / Beat Neuenschwander, Alessandro Matano, Zhongwen Tang, Satrajit Roychoudhury, Simon Wandel, Stuart Bailey -- 7. Statistical methodology for evaluation combination therapy in clinical trials / H.M. James Hung, Sue-Jane Wang -- 8. Challenges and opportunities in analysis of drug combination clinical trial data / Yaning Wang, Hao Zhu, Liang Zhao, and Ping Ji -- 9. Statistical computational tools for ADA analysis / Cheng Su |
| ctrlnum | (OCoLC)904798362 (DE-599)BVBBV042405910 |
| dewey-full | 615.19 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.19 |
| dewey-search | 615.19 |
| dewey-sort | 3615.19 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02519nmm a2200433zc 4500</leader><controlfield tag="001">BV042405910</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">150312s2015 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781482216752</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-4822-1675-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)904798362</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042405910</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Statistical methods in drug combination studies</subfield><subfield code="c">edited by Wei Zhao, MedImmune, LLC, Gaithersburg, Maryland, USA; Harry Yang, MedImmune, LLC, Gaithersburg, Maryland, USA.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boca Raton</subfield><subfield code="b">CRC Press</subfield><subfield code="c">[2015]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (235 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Chapman & Hall/CRC biostatistics series (Unnumbered)</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">1. Drug combination : much promise and many hurdles / Harry Yang and Laura Richman -- 2. Drug combination synergy / Harry Yang, Steven J. Novick, and Wei Zhao -- 3. Drug combination design strategies / Steven J. Novick and John J. Peterson -- 4. Confidence interval for interaction index / Maiying Kong and J. Jack Lee -- 5. Two-stage response surface approaches to modeling drug interaction / Wei Zhao and Harry Yang -- 6. A Bayesian industry approach to phase I combination trials in oncology / Beat Neuenschwander, Alessandro Matano, Zhongwen Tang, Satrajit Roychoudhury, Simon Wandel, Stuart Bailey -- 7. Statistical methodology for evaluation combination therapy in clinical trials / H.M. James Hung, Sue-Jane Wang -- 8. Challenges and opportunities in analysis of drug combination clinical trial data / Yaning Wang, Hao Zhu, Liang Zhao, and Ping Ji -- 9. Statistical computational tools for ADA analysis / Cheng Su</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Research</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Statistik</subfield><subfield code="0">(DE-588)4056995-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelforschung</subfield><subfield code="0">(DE-588)4003120-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Electronic books</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittelforschung</subfield><subfield code="0">(DE-588)4003120-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Statistik</subfield><subfield code="0">(DE-588)4056995-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhao, Wei</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yang, Harry</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">978-1-4822-1674-5</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-38-EBR</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027841520</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| id | DE-604.BV042405910 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T01:20:39Z |
| institution | BVB |
| isbn | 9781482216752 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027841520 |
| oclc_num | 904798362 |
| open_access_boolean | |
| physical | 1 Online-Ressource (235 pages) |
| psigel | ZDB-38-EBR |
| publishDate | 2015 |
| publishDateSearch | 2015 |
| publishDateSort | 2015 |
| publisher | CRC Press |
| record_format | marc |
| series2 | Chapman & Hall/CRC biostatistics series (Unnumbered) |
| spelling | Statistical methods in drug combination studies edited by Wei Zhao, MedImmune, LLC, Gaithersburg, Maryland, USA; Harry Yang, MedImmune, LLC, Gaithersburg, Maryland, USA. Boca Raton CRC Press [2015] 1 Online-Ressource (235 pages) txt rdacontent c rdamedia cr rdacarrier Chapman & Hall/CRC biostatistics series (Unnumbered) Includes bibliographical references and index 1. Drug combination : much promise and many hurdles / Harry Yang and Laura Richman -- 2. Drug combination synergy / Harry Yang, Steven J. Novick, and Wei Zhao -- 3. Drug combination design strategies / Steven J. Novick and John J. Peterson -- 4. Confidence interval for interaction index / Maiying Kong and J. Jack Lee -- 5. Two-stage response surface approaches to modeling drug interaction / Wei Zhao and Harry Yang -- 6. A Bayesian industry approach to phase I combination trials in oncology / Beat Neuenschwander, Alessandro Matano, Zhongwen Tang, Satrajit Roychoudhury, Simon Wandel, Stuart Bailey -- 7. Statistical methodology for evaluation combination therapy in clinical trials / H.M. James Hung, Sue-Jane Wang -- 8. Challenges and opportunities in analysis of drug combination clinical trial data / Yaning Wang, Hao Zhu, Liang Zhao, and Ping Ji -- 9. Statistical computational tools for ADA analysis / Cheng Su Drug development Drugs Research Statistik (DE-588)4056995-0 gnd rswk-swf Arzneimittelforschung (DE-588)4003120-2 gnd rswk-swf Electronic books Arzneimittelforschung (DE-588)4003120-2 s Statistik (DE-588)4056995-0 s 1\p DE-604 Zhao, Wei Sonstige oth Yang, Harry Sonstige oth Erscheint auch als Druck-Ausgabe, Hardcover 978-1-4822-1674-5 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Statistical methods in drug combination studies 1. Drug combination : much promise and many hurdles / Harry Yang and Laura Richman -- 2. Drug combination synergy / Harry Yang, Steven J. Novick, and Wei Zhao -- 3. Drug combination design strategies / Steven J. Novick and John J. Peterson -- 4. Confidence interval for interaction index / Maiying Kong and J. Jack Lee -- 5. Two-stage response surface approaches to modeling drug interaction / Wei Zhao and Harry Yang -- 6. A Bayesian industry approach to phase I combination trials in oncology / Beat Neuenschwander, Alessandro Matano, Zhongwen Tang, Satrajit Roychoudhury, Simon Wandel, Stuart Bailey -- 7. Statistical methodology for evaluation combination therapy in clinical trials / H.M. James Hung, Sue-Jane Wang -- 8. Challenges and opportunities in analysis of drug combination clinical trial data / Yaning Wang, Hao Zhu, Liang Zhao, and Ping Ji -- 9. Statistical computational tools for ADA analysis / Cheng Su Drug development Drugs Research Statistik (DE-588)4056995-0 gnd Arzneimittelforschung (DE-588)4003120-2 gnd |
| subject_GND | (DE-588)4056995-0 (DE-588)4003120-2 |
| title | Statistical methods in drug combination studies |
| title_auth | Statistical methods in drug combination studies |
| title_exact_search | Statistical methods in drug combination studies |
| title_full | Statistical methods in drug combination studies edited by Wei Zhao, MedImmune, LLC, Gaithersburg, Maryland, USA; Harry Yang, MedImmune, LLC, Gaithersburg, Maryland, USA. |
| title_fullStr | Statistical methods in drug combination studies edited by Wei Zhao, MedImmune, LLC, Gaithersburg, Maryland, USA; Harry Yang, MedImmune, LLC, Gaithersburg, Maryland, USA. |
| title_full_unstemmed | Statistical methods in drug combination studies edited by Wei Zhao, MedImmune, LLC, Gaithersburg, Maryland, USA; Harry Yang, MedImmune, LLC, Gaithersburg, Maryland, USA. |
| title_short | Statistical methods in drug combination studies |
| title_sort | statistical methods in drug combination studies |
| topic | Drug development Drugs Research Statistik (DE-588)4056995-0 gnd Arzneimittelforschung (DE-588)4003120-2 gnd |
| topic_facet | Drug development Drugs Research Statistik Arzneimittelforschung |
| work_keys_str_mv | AT zhaowei statisticalmethodsindrugcombinationstudies AT yangharry statisticalmethodsindrugcombinationstudies |